Cargando…

Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective

BACKGROUND: Estimates show that breast cancer, the leading cause of cancer death in females worldwide, will continue to increase in incidence, highlighting the need for increased treatment capacity. While postoperative radiation therapy (RT) is commonly used to reduce recurrence and mortality, resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Prince, Castilho, Marcus Simões, Marta, Gustavo Nader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903585/
https://www.ncbi.nlm.nih.gov/pubmed/36777322
http://dx.doi.org/10.1016/j.lana.2022.100292
_version_ 1784883499495325696
author Taylor, Prince
Castilho, Marcus Simões
Marta, Gustavo Nader
author_facet Taylor, Prince
Castilho, Marcus Simões
Marta, Gustavo Nader
author_sort Taylor, Prince
collection PubMed
description BACKGROUND: Estimates show that breast cancer, the leading cause of cancer death in females worldwide, will continue to increase in incidence, highlighting the need for increased treatment capacity. While postoperative radiation therapy (RT) is commonly used to reduce recurrence and mortality, research has shown that moderately hypofractionated radiation therapy (HFRT) and 5-fraction HFRT are equally safe and effective and can reduce treatment costs. This study aimed to compare the cost of conventional RT (50Gy/25), moderately HFRT (40.05Gy/15), and 5-fraction HFRT (26Gy/5) for breast cancer patients in Brazil. METHODS: The cost of each RT regimen was calculated using the International Atomic Energy Agency's Radiotherapy Cost Estimator Tool. The potential annual savings were then estimated by applying the cost of each regime to the 2020 Brazilian cancer incidence rates. FINDINGS: The average costs per patient for 25 fractions, 15 fractions, and 5 fractions are $2,699.20, $1,711.98, and $929.81, respectively. The annual cost savings associated with treating 70% of patients with 15 fraction HFRT and 30% of patients with 5 fraction HFRT as compared to treating all patients with 25 fraction RT is $72,929,315.40. The estimated annual productivity of 1 LINAC machine for 25 fractions, 15 fractions, and 5 fractions is 338, 647, and 1,310 patients, respectively. INTERPRETATION: The cost analysis revealed decreased patients’ costs and potential for increased EBRT access associated with HFRT in the Brazilian perspective. FUNDING: None.
format Online
Article
Text
id pubmed-9903585
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99035852023-02-10 Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective Taylor, Prince Castilho, Marcus Simões Marta, Gustavo Nader Lancet Reg Health Am Articles BACKGROUND: Estimates show that breast cancer, the leading cause of cancer death in females worldwide, will continue to increase in incidence, highlighting the need for increased treatment capacity. While postoperative radiation therapy (RT) is commonly used to reduce recurrence and mortality, research has shown that moderately hypofractionated radiation therapy (HFRT) and 5-fraction HFRT are equally safe and effective and can reduce treatment costs. This study aimed to compare the cost of conventional RT (50Gy/25), moderately HFRT (40.05Gy/15), and 5-fraction HFRT (26Gy/5) for breast cancer patients in Brazil. METHODS: The cost of each RT regimen was calculated using the International Atomic Energy Agency's Radiotherapy Cost Estimator Tool. The potential annual savings were then estimated by applying the cost of each regime to the 2020 Brazilian cancer incidence rates. FINDINGS: The average costs per patient for 25 fractions, 15 fractions, and 5 fractions are $2,699.20, $1,711.98, and $929.81, respectively. The annual cost savings associated with treating 70% of patients with 15 fraction HFRT and 30% of patients with 5 fraction HFRT as compared to treating all patients with 25 fraction RT is $72,929,315.40. The estimated annual productivity of 1 LINAC machine for 25 fractions, 15 fractions, and 5 fractions is 338, 647, and 1,310 patients, respectively. INTERPRETATION: The cost analysis revealed decreased patients’ costs and potential for increased EBRT access associated with HFRT in the Brazilian perspective. FUNDING: None. Elsevier 2022-06-09 /pmc/articles/PMC9903585/ /pubmed/36777322 http://dx.doi.org/10.1016/j.lana.2022.100292 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Taylor, Prince
Castilho, Marcus Simões
Marta, Gustavo Nader
Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective
title Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective
title_full Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective
title_fullStr Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective
title_full_unstemmed Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective
title_short Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective
title_sort cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the brazilian perspective
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903585/
https://www.ncbi.nlm.nih.gov/pubmed/36777322
http://dx.doi.org/10.1016/j.lana.2022.100292
work_keys_str_mv AT taylorprince costcontainmentanalysisandaccesstotreatmentassociatedwithadoptinghypofractionatedradiationtherapyfromthebrazilianperspective
AT castilhomarcussimoes costcontainmentanalysisandaccesstotreatmentassociatedwithadoptinghypofractionatedradiationtherapyfromthebrazilianperspective
AT martagustavonader costcontainmentanalysisandaccesstotreatmentassociatedwithadoptinghypofractionatedradiationtherapyfromthebrazilianperspective